PROM1 and lung carcinoma: Another pivotal study demonstrated that SFN attenuates gefitinib resistance in lung cancer cells by suppressing the expression of sonic hedgehog, smoothened, zinc finger protein GLI1, and stem cell markers CD133 and CD44, which resulted in inhibition of proliferation of gefitinib-resistant lung cancer cells [105].